Xin Zhang

机构：Fudan University, Shanghai Public Health Clinical Center, Nanjing Drum Tower Hospital, Zhongshan Hospital, Shanghai Clinical Research Center, Huashan Hospital, Shanghai Center for Brain Science and Brain-Inspired Technology, State Key Laboratory of Medical Neurobiology · ORCID：0000-0002-4814-6207

发表论文 35 篇 · 总被引 1148 次 · h-index 16

代表论文

• Atractylenolide III ameliorates Non-Alcoholic Fatty Liver Disease by activating Hepatic Adiponectin Receptor 1-Mediated AMPK Pathway (2022 · International Journal of Biological Sciences · 被引 126)
• Therapeutic potential of traditional Chinese medicine for the treatment of NAFLD: A promising drug Potentilla discolor Bunge (2022 · Acta Pharmaceutica Sinica B · 被引 56)
• Advances in the development of medical dressings for the treatment of diabetic foot wounds (2024 · Chemical Engineering Journal · 被引 45)
• Baicalein alleviates non-alcoholic fatty liver disease in mice by ameliorating intestinal barrier dysfunction (2023 · Food & Function · 被引 36)
• Global epidemiology of early-onset liver cancer attributable to specific aetiologies and risk factors from 2010 to 2019 (2023 · Journal of Global Health · 被引 31)
• Biological Role and Related Natural Products of SIRT1 in Nonalcoholic Fatty Liver (2023 · Diabetes Metabolic Syndrome and Obesity · 被引 28)